BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20031934)

  • 1. The evidence for the use of oral mucolytic agents in chronic obstructive pulmonary disease (COPD).
    Davies L; Calverley PM
    Br Med Bull; 2010; 93():217-27. PubMed ID: 20031934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Black PN
    Cochrane Database Syst Rev; 2010 Feb; (2):CD001287. PubMed ID: 20166060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease.
    Black PN; McDonald CF
    Postgrad Med J; 2009 Mar; 85(1001):141-7. PubMed ID: 19351641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medications for COPD: a review of effectiveness.
    Grimes GC; Manning JL; Patel P; Via RM
    Am Fam Physician; 2007 Oct; 76(8):1141-8. PubMed ID: 17990836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Black PN; Cates CJ
    Cochrane Database Syst Rev; 2012 Aug; (8):CD001287. PubMed ID: 22895919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM; Bollmeier SG; Finnegan PM
    Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of mucolytics in the management of COPD.
    Poole PJ
    Int J Chron Obstruct Pulmon Dis; 2006; 1(2):123-8. PubMed ID: 18046889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
    Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
    COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole PJ; Black PN
    Cochrane Database Syst Rev; 2006 Jul; (3):CD001287. PubMed ID: 16855965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical maintenance treatment of chronic obstructive pulmonary disease (COPD)].
    Kerstjens HA; Postma DS
    Ned Tijdschr Geneeskd; 2002 Aug; 146(35):1631-5. PubMed ID: 12233157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erdosteine for COPD exacerbations.
    Drug Ther Bull; 2008 Oct; 46(10):79-80. PubMed ID: 18832259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of corticosteroids in chronic obstructive pulmonary disease.
    Calverley PM
    Semin Respir Crit Care Med; 2005 Apr; 26(2):235-45. PubMed ID: 16088440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of mucolytics in COPD: A Delphi consensus study.
    Papi A; Avdeev S; Calverley PMA; Cordeiro CR; Jesenak M; Koblížek V; Petkova D; Rogliani P; Tarraf H; Tzanakis N; Ulmeanu R; Uzaslan E; Adir Y
    Respir Med; 2020 Dec; 175():106190. PubMed ID: 33217537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
    Suh DC; Lau H; La HO; Choi IS; Geba GP
    Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study.
    Zheng JP; Kang J; Huang SG; Chen P; Yao WZ; Yang L; Bai CX; Wang CZ; Wang C; Chen BY; Shi Y; Liu CT; Chen P; Li Q; Wang ZS; Huang YJ; Luo ZY; Chen FP; Yuan JZ; Yuan BT; Qian HP; Zhi RC; Zhong NS
    Lancet; 2008 Jun; 371(9629):2013-8. PubMed ID: 18555912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovations to achieve excellence in COPD diagnosis and treatment in primary care.
    Fromer L; Barnes T; Garvey C; Ortiz G; Saver DF; Yawn B
    Postgrad Med; 2010 Sep; 122(5):150-64. PubMed ID: 20861599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA
    Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data.
    Cazzola M; Floriani I; Page CP
    Pulm Pharmacol Ther; 2010 Apr; 23(2):135-44. PubMed ID: 19854285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.